Laboratories of Haematology

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


359 publications

... | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1998 |
2018
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
Cagnetta A., Soncini D., Orecchioni S., Talarico G., Minetto P., Guolo F., Retali V., Colombo N., Carminati E., Clavio M. et al., 2018/01. Haematologica, 103 (1) pp. 80-90. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A0458D4A8E8]
 
Diagnosis and treatment of follicular lymphoma: an update.
Bargetzi M., Baumann R., Cogliatti S., Dietrich P.Y., Duchosal M., Goede J., Hitz F., Konermann C., Lohri A., Mey U. et al., 2018. Swiss medical weekly, 148 pp. w14635. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53A025DE33E4]
Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
Passweg J.R., Baldomero H., Ansari M., Baerlocher G.M., Bargetzi M., Chalandon Y., Duchosal M.A., Gerull S., Güngör T., Halter J.P. et al., 2018. Swiss medical weekly, 148 pp. w14589. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E2D04A4B0AA3]
The Role of Plasma Transfusion in Massive Bleeding: Protecting the Endothelial Glycocalyx?
Barelli S., Alberio L., 2018. Frontiers in medicine, 5 p. 91. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_356CFFBE6C41]
2017
 
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
Nagler M., Angelillo-Scherrer A., Méan M., Limacher A., Abbal C., Righini M., Beer J.H., Osterwalder J., Frauchiger B., Aschwanden M. et al., 2017/11. Journal of thrombosis and haemostasis, 15 (11) pp. 2165-2175. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_83E81F84DC7C]
 
Vox Sanguinis International Forum on platelet cryopreservation.
Cohn C.S., Dumont L.J., Lozano M., Marks D.C., Johnson L., Ismay S., Bondar N., T'Sas F., Yokoyama APH, Kutner J.M. et al., 2017/10. Vox sanguinis, 112 (7) pp. e69-e85. Peer-reviewed.
[DOI][Pmid][serval:BIB_12778CF08954]
 
The storage lesions: From past to future.
Tissot J.D., Bardyn M., Sonego G., Abonnenc M., Prudent M., 2017/09. Transfusion clinique et biologique, 24 (3) pp. 277-284. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B41B8CF6B0F9]
 
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.
Studt J.D., Alberio L., Angelillo-Scherrer A., Asmis L.M., Fontana P., Korte W., Mendez A., Schmid P., Stricker H., Tsakiris D.A. et al., 2017/08. Journal of thrombosis and haemostasis, 15 (8) pp. 1576-1583. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A9A3D4C4BE3B]
T315I clone selection in a Ph+ all patient under low-dose ponatinib maintenance.
Noetzli J., Gavillet M., Masouridi-Levrat S., Duchosal M., Spertini O., 2017/08. Clinical case reports, 5 (8) pp. 1320-1322. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F5940E9F0C9D]
 
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Piacente F., Caffa I., Ravera S., Sociali G., Passalacqua M., Vellone V.G., Becherini P., Reverberi D., Monacelli F., Ballestrero A. et al., 2017/07/15. Cancer research, 77 (14) pp. 3857-3869. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D77736A5EF65]
 
Reversible granulocyte abnormalities after accidental ingestion of Colchicum autumnale.
Kritikos A., Spertini O., 2017/07/06. Blood, 130 (1) p. 95. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1BD5D7825A35]
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders
Orsini Sara, Noris Patrizia, Bury Loredana, Heller Paula G., Santoro Cristina, Kadir Rezan A., Butta Nora C., Falcinelli Emanuela, Cid Ana Rosa, Fabris Fabrizio et al., 2017/07. Haematologica, 102 (7) pp. 1192-1203.
[URN][DOI][WoS][Pmid][serval:BIB_40088583D110]
 
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study.
Bulla O., Poncet A., Alberio L., Asmis L.M., Gähler A., Graf L., Nagler M., Studt J.D., Tsakiris D.A., Fontana P., 2017/07. Haemophilia, 23 (4) pp. e335-e339. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_80FE0E631AD5]
 
Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery.
Kröll D., Stirnimann G., Vogt A., Lai DLL, Borbély Y.M., Altmeier J., Schädelin S., Candinas D., Alberio L., Nett P.C., 2017/07. British journal of clinical pharmacology, 83 (7) pp. 1466-1475. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_46251D8785FF]
 
Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia.
Casini A., Vilar R., Beauverd Y., Aslan D., Devreese K., Mondelaers V., Alberio L., Gubert C., de Moerloose P., Neerman-Arbez M., 2017/07. Haemophilia, 23 (4) pp. 583-589. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_46D3108BBF44]
 
Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation.
Alberio L., Ravanat C., Hechler B., Mangin P.H., Lanza F., Gachet C., 2017/06/02. Thrombosis and haemostasis, 117 (6) pp. 1101-1114. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB7ADCDA152B]
 
Impact of rivaroxaban on point-of-care assays.
Fontana P., Alberio L., Angelillo-Scherrer A., Asmis L.M., Korte W., Mendez A., Schmid P., Stricker H., Studt J.D., Tsakiris D.A. et al., 2017/05. Thrombosis research, 153 pp. 65-70. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1075B3F793FA]
Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion.
Sonego G., Abonnenc M., Tissot J.D., Prudent M., Lion N., 2017/04/11. International journal of molecular sciences, 18 (2) pp. E387.
[URN][DOI][WoS][Pmid][serval:BIB_33AFE8220365]
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.
Mantere T., Tervasmäki A., Nurmi A., Rapakko K., Kauppila S., Tang J., Schleutker J., Kallioniemi A., Hartikainen J.M., Mannermaa A. et al., 2017/04/06. Scientific reports, 7 (1) p. 681. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A9CC0DE5F356]
 
Innovative strategies for adverse karyotype acute myeloid leukemia.
Blum S., Greve G., Lübbert M., 2017/03. Current opinion in hematology, 24 (2) pp. 89-98. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD319BE75546]
 
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison.
Baumgartner A., Bargetzi M., Bargetzi A., Zueger N., Medinger M., Passweg J., Schanz U., Samaras P., Chalandon Y., Pichard C. et al., 2017/03. Nutrition, 35 pp. 43-50. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E75A3B6E6FA]
 
Gray platelet syndrome: Novel mutations of the NBEAL2 gene.
Bottega R., Nicchia E., Alfano C., Glembotsky A.C., Pastore A., Bertaggia-Calderara D., Bisig B., Duchosal M.A., Arbesú G., Alberio L. et al., 2017/02. American journal of hematology, 92 (2) pp. E20-E22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F5F46E612D6]
Laboratory Genetic Testing in Clinical Practice 2016.
Cogulu O., Schoumans J., Toruner G., Demkow U., Karaca E., Durmaz A.A., 2017. BioMed research international, 2017 p. 5798714. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_735C936910F9]
2016
 
Une douleur abdominale peu ordinaire ...
Freire Silvia, Vollenweider Peter, Alberio Lorenzo, Gavillet Mathilde, 2016/11/01. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (44).
[DOI][serval:BIB_E69A91CC3C6B]
 
Des céphalées trompeuses
Markopoulou Agni, Grandoni Francesco, Waeber Gérard, Alberio Lorenzo, Gavillet Mathilde, Kraege Vanessa, 2016/10/25. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (43) pp. 921-924. Peer-reviewed.
[DOI][serval:BIB_00D35A695A32]
Temps de thromboplastine partiel activé allongé, que faire?
Aslan Nurullah, Alberio Lorenzo, Blum Sabine, 2016/10/11. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (41).
[URN][DOI][serval:BIB_DCFE859A3A76]
The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner.
Heulot M., Chevalier N., Puyal J., Margue C., Michel S., Kreis S., Kulms D., Barras D., Nahimana A., Widmann C., 2016/09/27. Oncotarget, 7 (39) pp. 64342-64359. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F2DA0AC290B8]
 
Un purpura d'installation rapide...
de Sans Laura, Bart Pierre-Alexandre, Hohl Daniel, Neub Angela, Alberio Lorenzo, Voruz Sophie, 2016/06/21. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (25).
[DOI][serval:BIB_C3C032DE71C5]
 
Acquired intracoronary ADAMTS13 deficiency and VWF retention at sites of critical coronary stenosis in patients with STEMI.
Pedrazzini G., Biasco L., Sulzer I., Anesini A., Moccetti T., Kremer Hovinga J.A., Alberio L., 2016/06/09. Blood, 127 (23) pp. 2934-2936. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_12184E0D7BAA]
 
Response to correspondence: Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach by Ciepiela et al.
Williams D.A., Gavillet M., 2016/03. American journal of hematology, 91 (3) pp. E10. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BA69E18CECE]
 
Une hyperprotéinémie troublante
Beltraminelli Tim, Casutt Giulia, Alberio Lorenzo, Weber Gérard, Sartori Claudio, 2016/01/26. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (04).
[DOI][serval:BIB_C666FCB1E89C]
Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model.
Sociali G., Raffaghello L., Magnone M., Zamporlini F., Emionite L., Sturla L., Bianchi G., Vigliarolo T., Nahimana A., Nencioni A. et al., 2016/01/19. Oncotarget, 7 (3) pp. 2968-2984. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_93788DFD2BBE]
 
Guidelines for cytogenetic investigations in tumours.
Hastings R.J., Bown N., Tibiletti M.G., Debiec-Rychter M., Vanni R., Espinet B., van Roy N., Roberts P., van den Berg-de-Ruiter E., Bernheim A. et al., 2016/01. European journal of human genetics, 24 (1) pp. 6-13. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_238AFE37D7D9]
 
Guidelines for genomic array analysis in acquired haematological neoplastic disorders.
Schoumans J., Suela J., Hastings R., Muehlematter D., Rack K., van den Berg E., Berna Beverloo H., Stevens-Kroef M., 2016. Genes, Chromosomes and Cancer, 55 (5) pp. 480-491. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_16339C7307D0]
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky D.J., Abdelmohsen K., Abe A., Abedin M.J., Abeliovich H., Acevedo Arozena A., Adachi H., Adams C.M., Adams P.D., Adeli K. et al., 2016/01. Autophagy, 12 (1) pp. 1-222.
[URN][DOI][WoS][Pmid][serval:BIB_D1B3A2339998]
Ruxolitinib in the treatment of polycythemia vera: patient selection and special considerations.
Blum S., Martins F., Alberio L., 2016. Journal of Blood Medicine, 7 pp. 205-215. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AC50BBB0C2BA]
 
Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.
Gerber B., Alberio L., Rochat S., Stenner F., Manz M.G., Buser A., Schanz U., Stussi G., 2016. Transfusion, 56 (10) pp. 2426-2437. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0FBF2C6F7B79]
Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis.
Stalder G., Que Y.A., Calzavarini S., Burnier L., Kosinski C., Ballabeni P., Roger T., Calandra T., Duchosal M.A., Liaudet L. et al., 2016. PloS one, 11 (10) pp. e0163542. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AE9847158368]
 
Thromboembolie und Antikoagulation bei Tumorpatienten []
Grandoni F., Kaiser J., Blum S., Alberio L., 2016. Therapeutische Umschau. Revue therapeutique, 73 (10) pp. 595-604. Peer-reviewed.
[DOI][Pmid][serval:BIB_115AB0DBE476]
 
Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review.
Nagler M., Kremer Hovinga J.A., Alberio L., Peter-Salonen K., von Tengg-Kobligk H., Lottaz D., Neerman-Arbez M., Lämmle B., 2016. Thrombosis and Haemostasis, 116 (4) pp. 722-732. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE4017812B3E]
2015
 
Transfusion safety from the viewpoint of a musical quintet.
Garraud O., Tissot J.D., Osselaer J.C., Folléa G., Vernant J.P., Lefrère J.J., 2015/10. Blood transfusion = Trasfusione del sangue, 13 (4) p. 687. Peer-reviewed.
[DOI][Pmid][serval:BIB_7ECE6A1AC124]
 
Practical guidelines for Argatroban and Bivalirudin in patients with Heparin-induced Thrombocytopenia.
Colucci G., Nagler M., Klaus N., Conte T., Giabbani E., Alberio L., 2015/09/28. J Translational Science, 1 (2) pp. 37-42. Peer-reviewed.
[DOI][serval:BIB_3456191B0275]
 
Combinative effects of β-Lapachone and APO866 on pancreatic cancer cell death through reactive oxygen species production and PARP-1 activation.
Breton C.S., Aubry D., Ginet V., Puyal J., Heulot M., Widmann C., Duchosal M.A., Nahimana A., 2015. Biochimie, 116 pp. 141-153. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A4DEF65E413F]
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
Samaras P., Bargetzi M., Betticher D.C., Duchosal M.A., Heim D., Hess U., Ketterer N., Lerch E., Matthes T., Mey U. et al., 2015. Swiss Medical Weekly, 145 pp. w14100. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B8C497CD972]
 
Dysfibrinogenaemia associated with a novel heterozygous mutation in FGB (c.680delG) and a mild clinical history of bleeding.
Priovolos A., Neerman-Arbez M., Morris M., Angelillo-Scherrer A., Nötzli J., 2015. Blood Coagulation and Fibrinolysis, 26 (2) pp. 231-232. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_822D5551B04F]
Evolution of Genetic Techniques: Past, Present, and Beyond.
Durmaz A.A., Karaca E., Demkow U., Toruner G., Schoumans J., Cogulu O., 2015. Biomed Research International, 2015 p. 461524. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B7C00E8C5FE4]
 
Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
Nurden A.T., Pillois X., Fiore M., Alessi M.C., Bonduel M., Dreyfus M., Goudemand J., Gruel Y., Benabdallah-Guerida S., Latger-Cannard V. et al., 2015. Human Mutation, 36 (5) pp. 548-561. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6CD4327E979C]
 
In vitro assays and clinical trials in red blood cell aging: Lost in translation.
Prudent M., Tissot J.D., Lion N., 2015. Transfusion and Apheresis Science, 52 (3) pp. 270-276. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_99F4B95DA25F]
Laboratory genetic testing in clinical practice 2014.
Cogulu O., Schoumans J., Toruner G., Demkow U., Karaca E., Durmaz A.A., 2015. Biomed Research International, 2015 p. 574798.
[URN][DOI][WoS][Pmid][serval:BIB_E37B11FCE119]
Prediction of Post-Weaning Fibrinogen Status during Cardiopulmonary Bypass: An Observational Study in 110 Patients.
Erdoes G., Gerster G., Colucci G., Kaiser H., Alberio L., Eberle B., 2015. Plos One, 10 (5) pp. e0126692. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58A5D24DFDB5]
 
Progressive Organ Failure After Ingestion of Wild Garlic Juice
Galland-Decker C., Charmoy A., Jolliet P., Spertini O., Hugli O., Pantet O., 2015. Journal of Emergency Medicine, 50 (1) pp. 55-60. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8ED62DEA3ED3]
The potential use of microcalorimetry in rapid differentiation between septic arthritis and other causes of arthritis.
Yusuf E., Hügle T., Daikeler T., Voide C., Borens O., Trampuz A., 2015. European Journal of Clinical Microbiology and Infectious Diseases, 34 (3) pp. 461-465. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5BF1478F41A8]
2014
A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesis.
Ginet V., Puyal J., Rummel C., Aubry D., Breton C., Cloux A.J., Majjigapu S.R., Sordat B., Vogel P., Bruzzone S. et al., 2014. Autophagy, 10 (4) pp. 603-617.
[URN][DOI][WoS][Pmid][serval:BIB_E0EC16EEBAEC]
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies.
Breton C.S., Nahimana A., Aubry D., Macoin J., Moretti P., Bertschinger M., Hou S., Duchosal M.A., Back J., 2014. Journal of Hematology and Oncology, 7 p. 33. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_01E6AE78E68F]
 
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07).
Passweg J.R., Pabst T., Blum S., Bargetzi M., Li Q., Heim D., Stussi G., Gregor M., Leoncini L., Meyer-Monard S. et al., 2014. Leukemia and Lymphoma, 55 (1) pp. 87-91.
[DOI][WoS][Pmid][serval:BIB_EFBD423076BB]
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.
Gotta V., Widmer N., Decosterd L.A., Chalandon Y., Heim D., Gregor M., Benz R., Leoncini-Franscini L., Baerlocher G.M., Duchosal M.A. et al., 2014. Cancer Chemotherapy and Pharmacology, 74 (6) pp. 1307-1319. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8EFC5835C440]
 
High-dose therapy and autologous hematopoietic stem cell transplant in T-cell lymphoma: a single center experience.
Cairoli A., Ketterer N., Barelli S., Duchosal M.A., 2014. Leukemia and Lymphoma, 55 (8) pp. 1827-1831.
[DOI][WoS][Pmid][serval:BIB_B5FB5BD9936B]
 
The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody.
Nahimana A., Aubry D., Breton C.S., Majjigapu S.R., Sordat B., Vogel P., Duchosal M.A., 2014. Leukemia and Lymphoma, 55 (9) pp. 2141-2150.
[DOI][WoS][Pmid][serval:BIB_8DB096080B48]
 
The new direct oral anticoagulants in special indications: rationale and preliminary data in cancer, mechanical heart valves, anti-phospholipid syndrome, and heparin-induced thrombocytopenia and beyond.
Alberio L., 2014. Seminars in Hematology, 51 (2) pp. 152-156. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_196387084CAF]
2013
 
A novel use of thromboelastography in type 2B von Willebrand disease.
Toukh M., Ozelo M.C., Angelillo-Scherrer A., Othman M., 2013. International Journal of Laboratory Hematology, 35 (6) pp. e11-e14.
[DOI][WoS][Pmid][serval:BIB_B7A928F16C1F]
 
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.
Jantunen E., Boumendil A., Finel H., Luan J.J., Johnson P., Rambaldi A., Haynes A., Duchosal M.A., Bethge W., Biron P. et al., 2013. Blood, 121 (13) pp. 2529-2532.
[DOI][WoS][Pmid][serval:BIB_5E31A5BEE4AD]
 
Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).
Méan M., Aujesky D., Lämmle B., Gerschheimer C., Trelle S., Angelillo-Scherrer A., 2013. Journal of Thrombosis and Thrombolysis, 36 (4) pp. 484-491. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C609524CD3E8]
Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries.
Passweg J.R., Baldomero H., Bargetzi M., Bucher C., Chalandon Y., Duchosal M.A., Gratwohl A., Güngör T., Hess U., Leibundgut K. et al., 2013. Swiss Medical Weekly, 143 (143) pp. w13757.
[URN][DOI][Pmid][serval:BIB_A10CE93BD13E]
 
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation.
Calzavarini S., Villoutreix B.O., Lunghi B., Livaja R., Bernardi F., Dahlbäck B., 2013. Thrombosis and Haemostasis, 110 (1) pp. 31-38. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_828CDE251F10]
 
Myths: history, blood, sex and money.
Tissot J.D., Lion N., 2013. Blood Transfusion = Trasfusione del Sangue, 11 (1) pp. 1-3.
[DOI][WoS][Pmid][serval:BIB_B74BA0BAFDDE]
 
Myélome multiple : diagnostic et perspectives thérapeutiques
Cairoli A., Duchosal M.A., 2013. Swiss Medical Forum = Forum Médical Suisse, 13 (38) pp. 746-751.
[serval:BIB_E4BAF42E1257]
 
Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience.
Montecucco F., Cea M., Bauer I., Soncini D., Caffa I., Lasigliè D., Nahimana A., Uccelli A., Bruzzone S., Nencioni A., 2013. Current Drug Targets, 14 (6) pp. 637-643. Peer-reviewed.
[WoS][Pmid][serval:BIB_2F6E83FE64FD]
 
Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders.
Montecucco F., Cea M., Cagnetta A., Damonte P., Nahimana A., Ballestrero A., Rio A.D., Bruzzone S., Nencioni A., 2013. Current Topics in Medicinal Chemistry, 13 (23) pp. 2930-2938. Peer-reviewed.
[WoS][Pmid][serval:BIB_B7EE2B58FC75]
 
Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia.
Rabodonirina M., Vaillant L., Taffé P., Nahimana A., Gillibert R.P., Vanhems P., Hauser P.M., 2013. Emerging Infectious Diseases, 19 (1) pp. 21-28. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE80293E8EF4]
 
Questions et réponses sur l'utilisation du rivaroxaban (Xarelto) dans la pratique [Questions and answers regarding the use of rivaroxaban in daily practice].
groupe de travail RivaMoS Suisse, groupe Working Party on Haemostasis de la Société suisse d'hématologie, 2013. Revue Médicale Suisse, 9 (392) pp. 1375-1385. Peer-reviewed.
[Pmid][serval:BIB_211D237D6A6D]
 
Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation.
Rubin O., Delobel J., Prudent M., Lion N., Kohl K., Tucker E.I., Tissot J.D., Angelillo-Scherrer A., 2013. Transfusion, 53 (8) pp. 1744-1754.
[DOI][WoS][Pmid][serval:BIB_EC8284C97B27]
The effects of arterial flow on platelet activation, thrombus growth, and stabilization.
Cosemans J.M., Angelillo-Scherrer A., Mattheij N.J., Heemskerk J.W., 2013. Cardiovascular Research, 99 (2) pp. 342-352. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CDFBD073681]
 
Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoform.
Rochat B., Peduzzi D., McMullen J., Favre A., Kottelat E., Favrat B., Tissot J.D., Angelillo-Scherrer A., Bromirski M., Waldvogel S., 2013. Bioanalysis, 5 (20) pp. 2509-2520. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_313014089D6D]
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study.
Nagler M., Bachmann L.M., Alberio L., Angelillo-Scherrer A., Asmis L.M., Korte W., Mendez A., Reber G., Stricker H., Tsakiris D.A. et al., 2013. Thrombosis Journal, 11 (1) p. 6. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B2A91169F7A2]
2012
Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine.
Gavillet M., Noetzli J., Blum S., Duchosal M.A., Spertini O., Lambert J.F., 2012/12. Haematologica, 97 (12) pp. 1929-1931. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B9132A398C21]
 
Neutropenie und Fieber unklarer Genese [Neutropenia and fever of unknown origin]
Gavillet M., Medinger M., Tichelli A., Fux-Arnold C., 2012/11/28. Praxis, 101 (24) pp. 1573-1576. Peer-reviewed.
[DOI][Pmid][serval:BIB_9E995F5665D4]
 
Carence en fer sans anémie: où en est-on en 2012 [Iron deficiency without anemia: where are we in 2012?].
Favrat B., Waldvogel Abramowski S., Vaucher P., Cornuz J., Tissot J.D., 2012/11. Revue Médicale Suisse, 8 (364) pp. 2277-2281.
[Pmid][serval:BIB_B31054F22E84]
 
Guidelines for the use and interpretation of assays for monitoring autophagy.
Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A. et al., 2012/04. Autophagy, 8 (4) pp. 445-544. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_56859EA53CC8]
 
Catastrophic Complications of Intravenous Line Flushing with Unfractionated Heparin
Colucci Giuseppe, Jahns Maximilian, Silzle Tobias, Alberio Lorenzo, 2012. International Journal of Clinical Medicine, 03 (01) pp. 36-39.
[DOI][serval:BIB_C20E523E2A64]
 
Chronic idiopathic urticaria successfully treated by anticoagulant drugs.
Spring P., Angelillo-Scherrer A., Bigliardi P., 2012. European Journal of Dermatology, 22 (6) pp. 788-790.
[DOI][WoS][Pmid][serval:BIB_95D5408DF19A]
Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial.
Waldvogel Sophie, Pedrazzini Baptiste, Vaucher Paul, Bize Raphael, Cornuz Jacques, Tissot Jean-Daniel, Favrat Bernard, 2012. BMC Medicine, 10 (1) p. 8. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7DAE5488CF11]
Gammapathies monoclonales: Utilisation des chaînes légères libres sériques.
Aubert V., Duchosal M.A., 2012. Swiss Medical Forum, 12 (29) pp. 576-577.
[URN][serval:BIB_35719C47A1D5]
 
Is Less Chemotherapy Detrimental in Adults with Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Treated with High-Dose Imatinib? Results of the Prospective Randomized Graaph-2005 Study
Chalandon Y., Thomas X., Hayette S., Cayuela J.M., Abbal C., Huguet F., Raffoux E., Leguay T., Lepretre S., Escoffre-Barbe M. et al., 2012. pp. Abstract 138 dans ASH 2012, 54th Annual Meeting of the American Society of Hematology, Blood.
[WoS][serval:BIB_8C2747B9138D]
 
Leukocyte-derived microparticles in vascular homeostasis.
Angelillo-Scherrer A., 2012. Circulation Research, 110 (2) pp. 356-369.
[DOI][WoS][Pmid][serval:BIB_995F66457AE3]
 
Proteomic analysis of Intercept-treated platelets.
Prudent M., Crettaz D., Delobel J., Tissot J.D., Lion N., 2012. Journal of Proteomics, 76 (Spec. Is.) pp. 316-328. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AB49B111883F]
 
Quantification of the anticoagulatory effect of novel anticoagulants and management of emergencies
Gavillet M., Angelillo-Scherrer A., 2012. Médecine Cardiovasculaire = Kardiovaskuläre Medizin = Cardiovascular Medicine, 15 (5) pp. 170-179.
[serval:BIB_2D4474017435]
 
Red blood cell microparticles and blood group antigens: an analysis by flow cytometry.
Canellini G., Rubin O., Delobel J., Crettaz D., Lion N., Tissot J.D., 2012. Blood Transfusion = Trasfusione del Sangue, 10 (Suppl. 2) pp. s39-s45. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5B528AEF2F10]
 
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories.
Asmis L.M., Alberio L., Angelillo-Scherrer A., Korte W., Mendez A., Reber G., Seifert B., Stricker H., Tsakiris D.A., Wuillemin W.A., 2012. Thrombosis Research, 129 (4) pp. 492-498. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45EF032BD7EE]
 
Subcellular fractionation of stored red blood cells reveals a compartment-based protein carbonylation evolution.
Delobel J., Prudent M., Rubin O., Crettaz D., Tissot J.D., Lion N., 2012. Journal of Proteomics, 76 (Spec No.) pp. 181-193. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_08071938706F]
 
Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.
Germing U., Lauseker M., Hildebrandt B., Symeonidis A., Cermak J., Fenaux P., Kelaidi C., Pfeilstöcker M., Nösslinger T., Sekeres M. et al., 2012. Leukemia, 26 (6) pp. 1286-1292.
[DOI][WoS][Pmid][serval:BIB_3715D1EBA05D]
2011
A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants
Nahimana A., Aubry D., Lagopoulos L., Greaney P., Attinger A., Demotz S., Dawson K.M., Schapira M., Tschopp J., Dupuis M. et al., 2011. Blood Cancer Journal, 1 (12) pp. e47.
[URN][DOI][WoS][serval:BIB_F400AD0C819E]
 
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.
Bello C., Dal Bello G., Cea M., Nahimana A., Aubry D., Garuti A., Motta G., Moran E., Fruscione F., Pronzato P. et al., 2011. Bioorganic and Medicinal Chemistry, 19 (24) pp. 7720-7727.
[DOI][WoS][Pmid][serval:BIB_516406B5E329]
 
Brain water mobility decreases after astrocytic aquaporin-4 inhibition using RNA interference.
Badaut J., Ashwal S., Adami A., Tone B., Recker R., Spagnoli D., Ternon B., Obenaus A., 2011. Journal of Cerebral Blood Flow and Metabolism, 31 (3) pp. 819-831.
[DOI][WoS][Pmid][serval:BIB_3C337E3BAF28]
 
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib.
Haouala A., Widmer N., Duchosal M.A., Montemurro M., Buclin T., Decosterd L.A., 2011. Blood, 117 (8) pp. e75-e87. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E62C33C9D4C7]
 
Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based study.
Hamilton A., Ozelo M., Leggo J., Notley C., Brown H., Frontroth J.P., Angelillo-Scherrer A., Baghaei F., Enayat S.M., Favaloro E. et al., 2011. Thrombosis and Haemostasis, 105 (3) pp. 501-508.
[DOI][WoS][Pmid][serval:BIB_1144945020E6]
 
Inactivation des pathogènes des produits sanguins labiles: entre enjeux financiers et conséquences possibles à long terme [Pathogen reduction of blood components: from financial issues to possible long-term consequences].
Canellini G., Wasserfallen J.B., Tissot J.D., 2011. Transfusion Clinique et Biologique, 18 (4) pp. 493-497. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_540097E98FF2]
 
Insight in protein S deficiency from mouse models
Calzavarini S., Saller F., Fernandez J.A., Kadi L., Brisset A.C., Burnier L., Azevedo M., Ternon B., Griffin J.H., Angelillo-Scherrer A., 2011. pp. Abstract 529 dans 2011 American Society of Hematologie (ASH) 53rd Annual Meeting, Blood. Peer-reviewed.
[serval:BIB_ACFE9C7B53A7]
 
Le sang : arts, sciences, vie
Schneider P., Tissot J.D., Benzoni M., Ribes O. (eds.), 2011. 279, Favre.
[serval:BIB_A5FAA7115C36]
 
Le sang : passé, présent, futur
Tissot J.D., Buser A., 2011. pp. 10-22 dans Schneider P., Tissot J.D., Benzoni M., Ribes O. (eds.) Le Sang, Favre.
[serval:BIB_B87A6F8CDCC4]
 
Leukoagglutination reported as platelet clumps
Grob A. V., Angelillo-Scherrer A., 2011. Blood, 118 (11) p. 2940. Peer-reviewed.
[DOI][WoS][serval:BIB_B4482C2B709E]
 
Partager la vie : témoignages
Pascual M., 2011. pp. 160-173 dans Schneider P., Tissot J.D., Benzoni M., Ribes O. (eds.) Le sang : Arts, Sciences, Vie, Favre.
[serval:BIB_6C7DBA8191A7]
 
Pathogenèse des maladies cardiovasculaires chez les patients infectés par le VIH: un big bang encore non élucidé [Controversies regarding the pathogenesis of cardiovascular diseases in HIV patients].
Barelli S., Angelillo-Scherrer A., Foguena A.K., Periard D., Cavassini M., 2011. Revue Médicale Suisse, 7 (292) pp. 905-910.
[Pmid][serval:BIB_A005FD3220D9]
 
Perspectives de l'inactivation des pathogènes: quand la fiction dépasse la réalité [Back to the future: a fiction dealing with pathogen inactivation of blood products].
Canellini G., Tissot J.D., 2011. Transfusion Clinique et Biologique, 18 (5-6) p. 570.
[DOI][Pmid][serval:BIB_16E6C8725CE0]
Recommendations pour le diagnostic et le traitement de la leucémie lymphoïde chronique en Suisse. 1ère partie : Diagnostic, stadification et facteurs pronostiques
Gregor M., Bargetzi M., Duchosal M.A., Goede J.S., Heim D., Helg C., Korte W., Leoncini L., Solenthaler M., Zenhäusern R., 2011. Forum Médical Suisse, 11 (6) pp. 93-97.
[URN][serval:BIB_BC342385AC68]
Recommendations pour le diagnostic et le traitement de la leucémie lymphoïde chronique en Suisse. 2ème partie : Indications et stratégies thérapeutiques
Gregor M., Bargetzi M., Duchosal M.A., Goede J.S., Heim G., Helg C., Korte W., Leoncini L., Solenthaler M., Zenhäusern R., 2011. Forum Médical Suisse, 11 (7) pp. 118-124.
[URN][serval:BIB_D8DA44554150]
 
The GAP junction protein connexin37 regulates FVIII plasmatic activity
Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A., 2011. p. 32 dans 23rd Congress of the International Society on Thrombosis and Haemostasis, 57th Annual SSC Meeting, Journal of Thrombosis and Haemostasis. Peer-reviewed.
[WoS][serval:BIB_E01AD39C6BDA]
 
Thrombophilie: investiguer ou ne pas investiguer [Thrombophilia: is there a need to investigate?].
Méan M., Angelillo-Scherrer A., 2011. Revue Médicale Suisse, 7 (294) pp. 1025-1027.
[Pmid][serval:BIB_608CBBDAD937]
2010
 
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
Bello C., Cea M., Dal Bello G., Garuti A., Rocco I., Cirmena G., Moran E., Nahimana A., Duchosal M.A., Fruscione F. et al., 2010/05/01. Bioorganic & medicinal chemistry, 18 (9) pp. 3320-3334. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE0F7F1D0119]
 
Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
Novy J., Rosselet A., Spertini O., Lobrinus J.A., Pabst T., Kuntzer T., 2010/02. Muscle & nerve, 41 (2) pp. 286-287. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_864F3EA6F2FD]
 
5-Azacytidine to Treat Acute Myeloid Leukemia In Elderly or Frail Patients: A Phase II Study (SAKK 30/07).
Passweg J.R., Pabst T., Blum S., Bargetzi M., Sun H., Heim D., Stussi G., Gregor M., Leoncini L., Meyer-Monard S. et al., 2010. p. 900 dans 52nd Annual Meeting of the American Society of Hematology (ASH), Blood.
[WoS][serval:BIB_85F59D630C8B]
 
A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.
Mirasol Clinical Evaluation Study Group, 2010. Transfusion, 50 (11) pp. 2362-2375. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_10A1D0ECF464]
 
Acute myeloid leukemia with myeloid sarcoma and eosinophilia: prolonged remission and molecular response to imatinib.
Vedy Dana, Muehlematter Dominique, Rausch Thierry, Stalder Michele, Jotterand Martine, Spertini Olivier, 2010. Journal of Clinical Oncology, 28 (3) pp. e33-55.
[DOI][WoS][Pmid][serval:BIB_E51BF38E903E]
 
Analysis and clinical relevance of microparticles from red blood cells.
Tissot J.D., Rubin O., Canellini G., 2010. Current Opinion in Hematology, 17 (6) pp. 571-577.
[DOI][WoS][Pmid][serval:BIB_2031006D3542]
 
Blood proteomics.
Tissot J.D., 2010. Journal of Proteomics, 73 (3) pp. 466-467.
[DOI][WoS][Pmid][serval:BIB_3EC30CD72886]
 
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma.
Tenan M., Aurrand-Lions M., Widmer V., Alimenti A., Burkhardt K., Lazeyras F., Belkouch M.C., Hammel P., Walker P.R., Duchosal M.A. et al., 2010. Glia, 58 (5) pp. 524-537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19D881C05D13]
 
Diagnostic et prise en charge de la thrombocytopénie immune primaire
Keller P., Angelillo-Scherrer A., Bargetzi M., Goede J., Hess U., Imbach P., Kühne T., Mach-pascual S., Mey U., Rüfer A. et al., 2010. Swiss Medical Forum = Forum Médical Suisse, 10 (50) pp. 875-883.
[serval:BIB_3C7BE9A3A52E]
 
Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease.
Burnier L., Saller F., Kadi L., Brisset A.C., Sugamele R., Baudino L., Bono F., Herbert J.M., Carmeliet P., Schapira M. et al., 2010. Blood, 115 (16) pp. 3390-3397.
[DOI][WoS][Pmid][serval:BIB_923C5E3D1305]
 
Microparticles in stored red blood cells: submicron clotting bombs?
Rubin O., Crettaz D., Tissot J.D., Lion N., 2010. Blood Transfusion = Trasfusione Del Sangue, 8 Suppl 3 pp. s31-s38.
[DOI][WoS][Pmid][serval:BIB_F40723B327D6]
 
Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization.
Cosemans J.M., Van Kruchten R., Olieslagers S., Schurgers L.J., Verheyen F.K., Munnix I.C., Waltenberger J., Angelillo-Scherrer A., Hoylaerts M.F., Carmeliet P. et al., 2010. Journal of Thrombosis and Haemostasis : Jth, 8 (8) pp. 1797-1808.
[DOI][WoS][Pmid][serval:BIB_C7838D7ABE6C]
 
Pre-analytical and methodological challenges in red blood cell microparticle proteomics.
Rubin O., Crettaz D., Tissot J.D., Lion N., 2010. Talanta, 82 (1) pp. 1-8.
[DOI][WoS][Pmid][serval:BIB_7DB9BDD1C012]
 
Recommendations for the diagnosis and treatment of myelodysplastic syndromes in adult patients in Switzerland
Passweg J.R., Duchosal M.A., Hess U., Blum S., Freiburghaus A.U., Bargetzi M., Binder D., Dirnhofer St., Friess D., Goede J.S. et al., 2010. Swiss Medical Forum = Forum Médical Suisse, 10 (15) pp. 259-265.
[serval:BIB_D1F2EAA2AB70]
 
Recurrent postpartum cerebral sinus vein thrombosis as a presentation of cystathionine-beta-synthase deficiency.
Novy J., Ballhausen D., Bonafé L., Cairoli A., Angelillo-Scherrer A., Bachmann C., Michel P., 2010. Thrombosis and Haemostasis, 103 (4) pp. 871-873.
[DOI][WoS][Pmid][serval:BIB_151897DB36DD]
 
Results of An International Study of Quantitative BCR/ABL Assays Using Defined RNA Samples
Sher D. A., Miller J. E., Wei Q.i., Radich J. P., Wong C. L. P., Schrijver I.McNeil B. Kelly , Romeo E., Winstall E., Zamora L., Abbal C. et al., 2010. pp. 1130-1131 dans 52nd Annual Meeting of the American-Society-of-Hematology, Blood.
[WoS][serval:BIB_F5CA05F648E2]
 
Stored red blood cells: a changing universe waiting for its map(s).
Lion N., Crettaz D., Rubin O., Tissot J.D., 2010. Journal of Proteomics, 73 (3) pp. 374-385.
[DOI][WoS][Pmid][serval:BIB_BD8058AAC434]
Suivi thérapeutique de l'imatinib
Gotta V., Widmer N., Decosterd L.A., Csajka C., Duchosal M.A., Chalandon Y., Heim D., Gregor M., Buclin T., 2010. Forum Medical Suisse, 10 (23) pp. 403-406. Peer-reviewed.
[URN][serval:BIB_FE549E7D44DF]
Treatment of 5q-syndrome with lenalidomide in an HIV-positive patient under cART.
Blum Sabine, Cavassini Matthias, Lambert Jean-Francois, Fayet Aurelie, Schapira Marc, Jotterand Martine, 2010. Annals of Hematology, 89 (4) pp. 425-426.
[URN][DOI][WoS][Pmid][serval:BIB_6513BEF5AFEB]
2009
 
Cell-derived microparticles in haemostasis and vascular medicine.
Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A., 2009. Thrombosis and Haemostasis, 101 (3) pp. 439-451. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_664E63221815]
 
Generation and phenotypic analysis of protein s-deficient mice : OC-WE-037
Saller F., Brisset A.C., Azevedo M., Chrast R., Schapira M., Angelillo-Scherrer A., 2009. p. 216 dans 22nd Congress of the International Society on Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis.
[serval:BIB_3ABDAE17F621]
 
IFNalpha activates dormant haematopoietic stem cells in vivo.
Essers M.A., Offner S., Blanco-Bose W.E., Waibler Z., Kalinke U., Duchosal M.A., Trumpp A., 2009. Nature, 458 (7240) pp. 904-908. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8188D93E49A4]
Imatinib in breast milk
Kronenberger R., Schleyer E., Bornhaeuser M., Ehninger G., Gattermann N., Blum S., 2009. Annals Of Hematology, 88 (12) pp. 1265-1266.
[URN][DOI][WoS][serval:BIB_DC149A690971]
 
Intercellular communication in atherosclerosis.
Burnier L., Fontana P., Angelillo-Scherrer A., Kwak B.R., 2009. Physiology, 24 pp. 36-44. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE68FF1E5393]
 
NAD targeting efficiently kills hematologic cancer cells [Response]
Nahimana A., Aubry D., Butcher S., Duchosal M. A., 2009. Blood, 113 (23) pp. 6037-6038. Peer-reviewed.
[DOI][WoS][serval:BIB_A870C2501B89]
 
Novel role for connexin37 in FVIII secretion and coagulation : AS-TU-018
Burnier L., Pfenniger A., Sugamele R., Roth I., Delmar M., Fontana P., Kwak B.R., Angelillo-Scherrer A., 2009. p. 35 dans 22nd Congress of the International Society on Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis.
[serval:BIB_5EEE9E2BB9D1]
 
RNA interference against aquaporin-4 decreases the apparent diffusion coefficient in the normal brain
Badaut J., Ashwal S., Adami A., Tone B., Recker R., Ternon B., Obenaus A., 2009. pp. S91 dans 24th International Symposium on Cerebral Blood Flow and Metabolism/9th International Conference on Quantification of Brain Function with PET, Journal of Cerebral Blood Flow and Metabolism. Peer-reviewed.
[WoS][serval:BIB_A2B35152954A]
 
Temporal expression of AQP4 and neuroimaging in a juvenile rat model of traumatic brain injury
Badaut Jérôme, Obenaus André, Adami Arash, Ternon Béatrice, Tone Beatriz, Spagnoli David, Recker Becky, Ashwal Stephen, 2009. pp. S22-S23 dans 24th International Symposium on Cerebral Blood Flow and Metabolism/9th International Conference on Quantification of Brain Function with PET, Journal of Cerebral Blood Flow and Metabolism. Peer-reviewed.
[WoS][serval:BIB_C0793A3F9A8A]
 
Unexpected Role for Connexin37 in Circulating FVIII and Coagulation
Burnier Laurent, Pfenniger Anna, Taffet Steven, Delmar Mario, Fontana Pierre, Angelillo-Scherrer Anne, Kwak Brenda R., 2009. p. 1099 dans 82nd Scientific Session of the American Heart Association, Circulation. Peer-reviewed.
[WoS][serval:BIB_CD61B863786C]
2008
 
Diagnosis of systemic lupus erythematosus by bone marrow cytology
Ferrario Chiara, Quarroz Stéphane, Angelillo-Scherrer Anne, 2008/08. BloodMed.com pp. 10/08/2008.
[serval:BIB_9062433231FF]
 
LE cells in incubated bone marrow
Ferrario Chiara, Quarroz Stéphane, Angelillo-Scherrer Anne, 2008/08. BloodMed.com pp. 10/08/2008.
[serval:BIB_222EE6699362]
 
SLE diagnosed from bone marrow
Ferrario Chiara, Quarroz Stéphane, Angelillo-Scherrer Anne, 2008/08. BloodMed.com pp. 10/08/2008.
[serval:BIB_F1B9899186AC]
 
Erhebung zur immunsuppressiven Therapie der erworbenen Hämophilie in Deutschland, Österreich und der Schweiz
Huth-Kühne A., Oldenburg J., Großmann R., Geisen U., Krause M., Brand B., Alberio L., Klamroth R., Spannagl M., Knöbl P. et al., 2008. Hämostaseologie, 28 (S 01) pp. S29-S30.
[DOI][serval:BIB_10F460ED0E36]
 
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome
Knipp S., Strupp C., Gattermann N., Hildebrandt B., Schapira M., Giagounidis A., Aul C., Haas R., Germing U., 2008. Leukemia Research, 32 (1) pp. 33-37.
[DOI][Pmid][serval:BIB_391FDDCFFD30]
Radiological profile of anemia on unenhanced MDCT of the thorax.
Kamel E.M., Rizzo E., Duchosal M.A., Duran R., Goncalves-Matoso V., Schnyder P., Qanadli S.D., 2008. European Radiology, 18 (9) pp. 1863-1868. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F7A2A5D4FFF1]
2007
 
Clinical consequences of imatinib plasma concentrations variability in hemato-oncologic patients
Widmer N., Leyvraz S., Duchosal M.A., Rosselet A., Csajka C., Henry H., Debiec-Rychter M., Eap C.B., Biollaz J., Buclin T. et al., 2007. p. 481 dans 10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), Therapeutic Drug Monitoring. Peer-reviewed.
[WoS][serval:BIB_6B840EC11A9C]
 
Proteomic and transcriptomic analysis of human CD8(+) T lymphocytes over-expressing telomerase.
Thadikkaran L., Menzel O., Tissot J.D., Rufer N., 2007. Proteomics. Clinical Applications, 1 (3) pp. 299-311.
[DOI][WoS][Pmid][serval:BIB_F0B170003C9A]
 
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-up.
Bessoud B., Duchosal M.A., Siegrist C.A., Schlegel S., Doenz F., Calmes J.M., Qanadli S.D., Schnyder P., Denys A., 2007. Journal of Trauma, 62 (6) pp. 1481-1486.
[DOI][WoS][Pmid][serval:BIB_0F49740891A4]
2006
 
Geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations within Western Europe
Rabodonirina M., Nahimana A., Weber R., Francioli P., Bille J., Hauser P. M., 2006. Journal of Eukaryotic Microbiology, 53 Suppl 1 pp. S112-3.
[DOI][WoS][Pmid][serval:BIB_446D86F22395]
2005
 
Molecular evidence of Pneumocystis transmission in pediatric transplant unit
Hocker B., Wendt C., Nahimana A., Tonshoff B., Hauser P. M., 2005/02. Emerging Infectious Diseases, 11 (2) pp. 330-2.
[WoS][Pmid][serval:BIB_B23005632BDD]
2004
Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients.
Rabodonirina M., Vanhems P., Couray-Targe S., Gillibert R.P., Ganne C., Nizard N., Colin C., Fabry J., Touraine J.L., van Melle G. et al., 2004. Emerging infectious diseases, 10 (10) pp. 1766-73. Peer-reviewed.
[URN][Pmid][serval:BIB_E98098077C99]
2003
Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients
Nahimana A., Rabodonirina M., Zanetti G., Meneau I., Francioli P., Bille J., Hauser P. M., 2003/10. Journal of Infectious Diseases, 188 (7) pp. 1017-23.
[URN][DOI][WoS][Pmid][serval:BIB_79DA7A2E9F6F]
 
Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia
Nahimana A., Rabodonirina M., Helweg-Larsen J., Meneau I., Francioli P., Bille J., Hauser P. M., 2003/07. Emerging Infectious Diseases, 9 (7) pp. 864-7.
[WoS][Pmid][serval:BIB_B5C359953C66]
 
Pneumocystis jirovecii dihydrofolate reductase polymorphisms associated with failure of prophylaxis
Nahimana A., Rabodonirina M., Francioli P., Bille J., Hauser P. M., 2003. Journal of Eukaryotic Microbiology, 50 Suppl pp. 656-7.
[DOI][WoS][Pmid][serval:BIB_25A9A5B7D5DB]
2002
 
Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface
Dale George L., Friese Paul, Batar Peter, Hamilton Stephen F., Reed Guy L., Jackson Kenneth W., Clemetson Kenneth J., Alberio Lorenzo, 2002/01. Nature, 415 (6868) pp. 175-179.
[DOI][WoS][Pmid][serval:BIB_EBCA03DF53DF]
2001
 
Rapid PCR-single-strand conformation polymorphism method to differentiate and estimate relative abundance of Pneumocystis carinii special forms infecting rats
Nahimana A., Cushion M. T., Blanc D. S., Hauser P. M., 2001/12. Journal of Clinical Microbiology, 39 (12) pp. 4563-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_676A20EBBD4B]
 
Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing
Hauser P. M., Blanc D. S., Sudre P., Senggen Manoloff E., Nahimana A., Bille J., Weber R., Francioli P., 2001/03. AIDS, 15 (4) pp. 461-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DCE7F682C21A]
 
Douze ans de transplantation hépatique à Lausanne [Twelve years of liver transplantation in Lausanne]
Mosimann F., Bettschart V., Gardaz J.P., Fontolliet C., Tissot J.D., Meuwly J.Y., Chioléro R., Gillet M., 2001/02. Revue Médicale de la Suisse romande, 121 (2) pp. 95-99.
[Pmid][serval:BIB_7F0B6F67474F]
2000
 
Determination of the copy number of the nuclear rDNA and beta-tubulin genes of Pneumocystis carinii f. sp. hominis using PCR multicompetitors
Nahimana A., Francioli P., Blanc D. S., Bille J., Wakefield A. E., Hauser P. M., 2000/08. Journal of Eukaryotic Microbiology, 47 (4) pp. 368-72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E54F8EBD3D9D]
 
Typing of Pneumocystis carinii f. sp. hominis by PCR-SSCP to indicate a high frequency of co-infections
Nahimana A., Blanc D. S., Francioli P., Bille J., Hauser P. M., 2000/08. Journal of Medical Microbiology, 49 (8) pp. 753-8. Peer-reviewed.
[WoS][Pmid][serval:BIB_309BA0372A2C]
 
Carriage of Pneumocystis carinii by immunosuppressed patients and molecular typing of the organisms
Hauser P. M., Blanc D. S., Bille J., Nahimana A., Francioli P., 2000/03. AIDS, 14 (4) pp. 461-3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_028DB3FD90EF]
1998
 
Potential coinfections complicate typing of Pneumocystis carinii f. sp. hominis
Hauser P. M., Blanc D. S., Telenti A., Nahimana A., Bille J., Francioli P., 1998/10. Journal of Clinical Microbiology, 36 (10) p. 3111. Peer-reviewed.
[WoS][Pmid][serval:BIB_95C853408545]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University